Product Information
METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.9092 per EA under NDC 62332011531. Its NADAC has been published 565 times since Dec 9, 2015.
FDA first approved this application on Nov 6, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 50 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332011531
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA202870FDA Approved
11/6/2013
TE Code
AB
On Market Since
10/15/2015
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB has been published 565 times since Dec 9, 2015, and over the history we have for it it has risen 14.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9092 per EA |
|---|---|
| All-time high | $1.1404 (Jun 12, 2019) |
| All-time low | $0.6260 (Jun 19, 2024) |
| 52-week high | $1.0451 |
| 52-week low | $0.9092 |
| Median price | $0.9626 |
| Average price | $0.9349 |
| Largest weekly change | +30.7% (Sep 19, 2018) |
| Weeks tracked | 565 |
| Tracking since | Dec 9, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol Tartrate and Hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Thiazide Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB, manufactured by Alembic Pharmaceuticals Inc., is $0.9092 per EA (NDC 62332011531), effective Sep 30, 2026.
How has the price of METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB has risen 14.2%. It has been tracked across 565 weekly CMS publications since Dec 9, 2015.
What are the highest and lowest recorded NADAC prices for METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB?
Since Dec 9, 2015, the NADAC for METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB has ranged from a low of $0.6260 (Jun 19, 2024) to a high of $1.1404 (Jun 12, 2019), with a median of $0.9626 per EA.
Are there cheaper alternatives to METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB?
METOPROLOL-HYDROCHLOROTHIAZIDE 50-25 MG TAB (NDC 62332011531) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.